This announcement is a separate document:
ジーエヌアイグループ：F230の中国における新薬臨床試験開始申請（IND）承認に関するお知らせ
GNI Group: Notice regarding approval of F230 New Drug Clinical Trial Commencement Application (IND) in China
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.